2069 - Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study

03:00pm - 04:00pm ET

Presenter(s)

Hong Ge, MD - The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou,